{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:27:31Z","timestamp":1780583251055,"version":"3.54.1"},"reference-count":47,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[2019,4]]},"abstract":"<jats:p>Volume management in acute decompensated and chronic heart failure (HF) remains a significant challenge. Although progress has been made in the development of mortality\u2010reducing neurohormonal regimens in the reduced ejection fraction population, no clinical trial has yet demonstrated anything more than symptomatic relief or biomarker reduction with pharmacotherapeutic volume\u2010based interventions made in the acutely decompensated individual or those with evolving outpatient congestion. As the number of patients with HF continues to grow, in addition to HF\u2010related hospitalizations, identifying therapies that have the potential to aid in diuresis more safely and efficaciously is paramount to decreasing inpatient length of stay and preventing unnecessary admissions. More recently, a significant amount of research has been dedicated to the use of vasopressin antagonists, specifically tolvaptan, as adjunctive therapy to loop and thiazide diuretics. Although these agents do not seem to have a pervasive role in fluid management in the acute decompensated and chronic HF populations, they are effective tools to have available for specific clinical situations. This review summarizes the literature surrounding the use of tolvaptan for volume management in congestive HF, as well as offering practical guidance for use of this agent.<\/jats:p>","DOI":"10.1002\/phar.2239","type":"journal-article","created":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T01:49:39Z","timestamp":1551145779000},"page":"473-485","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Tolvaptan for Volume Management in Heart Failure"],"prefix":"10.1002","volume":"39","author":[{"given":"Erik G.","family":"Gunderson","sequence":"first","affiliation":[{"name":"University of Iowa College of Pharmacy Iowa City Iowa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew P.","family":"Lillyblad","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Abbott Northwestern Hospital Minneapolis Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Fine","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Northwestern Memorial Hospital Chicago Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orly","family":"Vardeny","sequence":"additional","affiliation":[{"name":"University of Minnesota Medical School Twin Cities Minneapolis Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4473-7517","authenticated-orcid":false,"given":"Theodore J.","family":"Berei","sequence":"additional","affiliation":[{"name":"Department of Pharmacy University of Wisconsin Hospitals and Clinics Madison Wisconsin"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,4]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-017-0598-y"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000558"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.15420\/cfr.2016:25:2"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000350"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2004.08.005"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi845"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2006.09.011"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.15420\/cfr.2015.1.2.90"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1409077"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61198-1"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2014.05.007"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2015.07.021"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.14740\/cr553w"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.09.004"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.282190"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2016.02.007"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.12088"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.12.035"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-011-6304-x"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.02.095"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.12.1332"},{"issue":"16","key":"e_1_2_9_23_1","first-page":"e240","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"128","author":"Yancy CW","year":"2013","journal-title":"Circulation"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.19.2581"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2012.06.415"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(94)90385-9"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.16.1963"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.01.091"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2007.04.008"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2003.166"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00195.2005"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1005419"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.12.1319"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehl542"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.112.000106"},{"key":"e_1_2_9_36_1","unstructured":"Otsuka Pharmaceutical Co. Ltd.SAMSCA (tolvaptan) [package insert].Tokyo Japan;2018."},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa065181"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2011.08.005"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.112.969246"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2013.04.001"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-17-0179"},{"key":"e_1_2_9_42_1","unstructured":"GuptaD.Aiding diuresis with tolvaptan (ADD\u2010IT). Clinical Trials.gov. Bethesda MD: National Library of Medicine. Available fromhttps:\/\/clinicaltrials.gov\/ct2\/show\/NCT02646540. Accessed May 23 2018."},{"key":"e_1_2_9_43_1","unstructured":"CoxZ.Comparison of oral thiazides vs intravenous thiazides vs tolvaptan in combination with loop diuretics for diuretic resistant decompensated heart failure. ClinicalTrials.gov. Bethesda MD: National Library of Medicine. Available fromhttps:\/\/clinicaltrials.gov\/ct2\/show\/NCT02606253. Accessed May 23 2018."},{"key":"e_1_2_9_44_1","unstructured":"NgT ElkayamU.Aquaresis utility for hyponatremic acute heart failure study (AQUA\u2010AHF). ClinicalTrials.gov. Bethesda MD: National Library of Medicine. Available fromhttps:\/\/clinicaltrials.gov\/ct2\/show\/NCT02183792. Accessed May 23 2018."},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1159\/000360604"},{"key":"e_1_2_9_46_1","unstructured":"AdamsKF.Tolvaptan treatment to reverse worsening outpatient heart failure: possible role of copeptin in identifying responders (TROUPER). ClinicalTrials.gov. Bethesda MD: National Library of Medicine. Available fromhttps:\/\/clinicaltrials.gov\/ct2\/show\/NCT02476409. Accessed May 23 2018."},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfr049"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI107423"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fphar.2239","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/phar.2239","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/phar.2239","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/phar.2239","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:16:27Z","timestamp":1761052587000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1002\/phar.2239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["10.1002\/phar.2239"],"URL":"https:\/\/doi.org\/10.1002\/phar.2239","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"value":"0277-0008","type":"print"},{"value":"1875-9114","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"2019-04-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}